| AIM2 |
O14862
|
absent in melanoma 2
|
|
2.2E-09 |
0.521 |
0.769 |
| CCR8 |
P51685
|
C-C motif chemokine receptor 8
|
G-protein coupled receptor
|
7.7E-03 |
0.597 |
0.692 |
| CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
| CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
| CXCL9 |
Q07325
|
C-X-C motif chemokine ligand 9
|
Signaling
|
2.9E-03 |
0.462 |
0.808 |
| CXCR3 |
P49682
|
C-X-C motif chemokine receptor 3
|
G-protein coupled receptor
|
0.18 |
0.436 |
0.808 |
| CASP1 |
P29466
|
caspase 1
|
Enzyme
|
3.5E-05 |
0.413 |
0.885 |
| CD69 |
Q07108
|
CD69 molecule
|
|
3.0E-02 |
0.488 |
0.923 |
| CD86 |
P42081
|
CD86 molecule
|
|
0.95 |
0.483 |
0.769 |
| PPIP5K1 |
Q6PFW1
|
diphosphoinositol pentakisphosphate kinase 1
|
|
2.7E-03 |
0.700 |
0.308 |
| ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| FGF21 |
Q9NSA1
|
fibroblast growth factor 21
|
Signaling
|
2.9E-02 |
0.485 |
0.769 |
| FLT3LG |
P49771
|
fms related receptor tyrosine kinase 3 ligand
|
|
0.94 |
0.564 |
0.577 |
| GPT |
P24298
|
glutamic--pyruvic transaminase
|
Enzyme
|
3.6E-19 |
0.403 |
0.923 |
| GZMB |
P10144
|
granzyme B
|
Enzyme
|
3.7E-14 |
0.453 |
0.808 |
| HAVCR2 |
Q8TDQ0
|
hepatitis A virus cellular receptor 2
|
|
3.9E-02 |
0.450 |
0.808 |
| ISYNA1 |
Q9NPH2
|
inositol-3-phosphate synthase 1
|
|
2.5E-05 |
0.510 |
0.769 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| IFNAR2 |
P48551
|
interferon alpha and beta receptor subunit 2
|
Receptor
|
8.5E-06 |
0.585 |
0.731 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IFI16 |
Q16666
|
interferon gamma inducible protein 16
|
Transcription factor
|
1.8E-11 |
0.603 |
0.769 |
| IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
| IL1RN |
P18510
|
interleukin 1 receptor antagonist
|
|
3.1E-02 |
0.373 |
0.923 |